Cyclamide

From WikiMD's Wellness Encyclopedia

Aerucyclamide_A.svg

Cyclamide is a chemical compound that belongs to the class of alkylating agents. It is primarily used in the field of medicine for its antineoplastic properties, meaning it is utilized in the treatment of various types of cancer.

Chemical Structure and Properties[edit | edit source]

Cyclamide is characterized by its ability to form covalent bonds with DNA, leading to the disruption of DNA replication and transcription. This property makes it effective in inhibiting the growth of rapidly dividing cells, such as cancer cells. The chemical structure of cyclamide includes an alkyl group that can transfer to DNA, causing cross-linking and subsequent cell death.

Medical Uses[edit | edit source]

Cyclamide is commonly used in chemotherapy regimens for the treatment of cancers such as lymphoma, leukemia, and breast cancer. It is often administered in combination with other chemotherapeutic agents to enhance its efficacy. The drug is known for its ability to target and kill cancer cells, although it can also affect normal, healthy cells, leading to side effects.

Side Effects[edit | edit source]

The use of cyclamide can result in a range of side effects, which may include:

Mechanism of Action[edit | edit source]

Cyclamide works by adding an alkyl group to the DNA molecule, which interferes with the DNA's ability to replicate and transcribe. This alkylation process leads to the formation of cross-links within the DNA strands, preventing the cancer cells from dividing and ultimately causing cell death.

History[edit | edit source]

Cyclamide was first developed in the mid-20th century and has since become a staple in the treatment of various cancers. Its discovery marked a significant advancement in the field of oncology, providing a new tool for combating malignancies.

Research and Development[edit | edit source]

Ongoing research continues to explore new applications and formulations of cyclamide to improve its efficacy and reduce its side effects. Studies are also being conducted to understand the mechanisms of resistance that some cancer cells develop against cyclamide, with the aim of overcoming these challenges.

See Also[edit | edit source]

References[edit | edit source]

External Links[edit | edit source]

Contributors: Prab R. Tumpati, MD